Keys and pathways to more precise medicine

Shaping the future of drug discovery

A New Age of Drug Discovery

At Switzerland Innovation Park Innovaare, interdisciplinary collaborations between science and industry can flourish, thereby enabling the discovery of keys and pathways leading to more precise medicine.

To solve the riddle of a drug, to find the right target and to understand exactly how it influences processes within a human cell, scientists from a variety of fields need to come together and work together: biologists, chemists, crystallographers, bioengineers, computer scientists and even physicists and engineers. Throughout this collaboration, industry discovers how to translate a joint scientific effort into a new innovative product.

The future is in structure-based drug discovery

SCIENTIFIC EXCELLENCE

Our partner and geographical neighbor the Paul Scherrer Institute (PSI) is Switzerland's largest research center for natural and engineering sciences. It employs more than 2,000 specialists conducting cutting-edge research.

Every year, thousands of scientists around the world come to PSI to use our unique facilities to carry out experiments that are not possible anywhere else. In the links on your right, you will find further information related to these facilities and the experiments that can be conducted here.

Life Science basic research on the top level

×
Recently inaugurated, SwissFEL will enable researchers to perform time-resolved structure determination of biological specimens.

Recently inaugurated, SwissFEL will enable researchers to perform time-resolved structure determination of biological specimens.

Laboratory of Biomolecular Research (LBR)

The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s large research infrastructures, including the synchrotron Swiss Light Source SLS and, most recently, the Swiss X-Ray Free-Electron Laser SwissFEL. It is also home to the world’s first pencil beam scanning proton therapy facility. Along with matter and materials, energy and environment, human health is a strategic focus area of the research activities at the PSI. The Institute provides perfect conditions for basic and translational biological research. In the last two years, several PSI spin-off companies have been established in or relocated to PARK INNOVAARE.

Laboratory of Biomolecular Research (LBR)

The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s large research infrastructures, including the synchrotron Swiss Light Source SLS and, most recently, the Swiss X-Ray Free-Electron Laser SwissFEL. It is also home to the world’s first pencil beam scanning proton therapy facility. Along with matter and materials, energy and environment, human health is a strategic focus area of the research activities at the PSI. The Institute provides perfect conditions for basic and translational biological research. In the last two years, several PSI spin-off companies have been established in or relocated to PARK INNOVAARE.

Infrastructure and R&D solutions

×
The Swiss Light Source (SLS) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability for research in material science, biology and chemistry.

The Swiss Light Source (SLS) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability for research in material science, biology and chemistry.

Large-scale research facilities and their applications

The combination of cutting-edge technologies and methods available at the Paul Scherrer Institute (PSI) helps scientists and user companies achieve unprecedented results in their research activities. Already today, the companies at PARK INNOVAARE offer unique structure identification services, such as rapid, nondestructive analysis of multicomponent mixtures, powerful method for determining absolute configuration, data collection from nanocrystals, and cutting-edge research on membrane protein structure.

Large-scale research facilities and their applications

The combination of cutting-edge technologies and methods available at the Paul Scherrer Institute (PSI) helps scientists and user companies achieve unprecedented results in their research activities. Already today, the companies at PARK INNOVAARE offer unique structure identification services, such as rapid, nondestructive analysis of multicomponent mixtures, powerful method for determining absolute configuration, data collection from nanocrystals, and cutting-edge research on membrane protein structure.

FUNDING & INFRASTRUCTURE

One of the core advantages of our innovation campus is the unique combination it offers of state-of-the-art research facilities, high-end office and lab space as well as an expanding high-tech entrepreneurship ecosystem.

This valuable set-up is completed with funding and investment opportunities as well as a wide network of national and international research institutes, SMEs and large companies.

PARK INNOVAARE for biotech and pharma

×
PARK INNOVAARE is responding to the increasing demand for highly flexible, easy-to-access laboratories.

PARK INNOVAARE is responding to the increasing demand for highly flexible, easy-to-access laboratories.

Prof. Daniel Kündig, CEO
PARK INNOVAARE: deliveryLAB
5234 Villigen
innovation@parkinnovaare.ch

PARK INNOVAARE provides the best possible operating conditions for biotech and pharmaceutical companies. This includes the availability of modern laboratories and office space. Already eight high-tech companies have joined the site, located just a stone’s throw away from the Paul Scherrer Institute (PSI). Four of these companies are active in the pharmaceutical, chemical and biotech industries and benefit from PARK INNOVAARE’s perfect environment. One of the most crucial factors for these young companies – as well as for the R&D units of large enterprises – is accessible, state-of-the-art lab and office space. Although the market offers a lot of opportunities, the possibility to work directly on the campus of a university or research institute, such as the Paul Scherrer Institute (PSI), is rare.

Prof. Daniel Kündig, CEO
PARK INNOVAARE: deliveryLAB
5234 Villigen
innovation@parkinnovaare.ch

PARK INNOVAARE provides the best possible operating conditions for biotech and pharmaceutical companies. This includes the availability of modern laboratories and office space. Already eight high-tech companies have joined the site, located just a stone’s throw away from the Paul Scherrer Institute (PSI). Four of these companies are active in the pharmaceutical, chemical and biotech industries and benefit from PARK INNOVAARE’s perfect environment. One of the most crucial factors for these young companies – as well as for the R&D units of large enterprises – is accessible, state-of-the-art lab and office space. Although the market offers a lot of opportunities, the possibility to work directly on the campus of a university or research institute, such as the Paul Scherrer Institute (PSI), is rare.

Get more out of your R&D activities

×
Switzerland Innovation creates a platform where groundbreaking researchers, innovative companies, and entrepreneurs can work together.

Switzerland Innovation creates a platform where groundbreaking researchers, innovative companies, and entrepreneurs can work together.

Raymond Cron, CEO
Switzerland Innovation
Monbijoustrasse 15
3011 Bern
info@switzerland-innovation.com

As a network of Swiss innovation parks, Switzerland Innovation provides a platform for corporate R&D teams to collaborate with leading scientists from academia, industry partners and pioneering start-ups. It facilitates access to the expertise of the world’s leading universities, such as Swiss Federal Institutes of Technology ETH Zurich and EPFL, and the Paul Scherrer Institute (PSI). Companies collaborating with PARK INNOVAARE, one of Switzerland Innovation’s five sites, benefit from technology transfer platforms, state-of-the-art infrastructure and a unique atmosphere, which together foster the creation of the next best-selling products and services.

Raymond Cron, CEO
Switzerland Innovation
Monbijoustrasse 15
3011 Bern
info@switzerland-innovation.com

As a network of Swiss innovation parks, Switzerland Innovation provides a platform for corporate R&D teams to collaborate with leading scientists from academia, industry partners and pioneering start-ups. It facilitates access to the expertise of the world’s leading universities, such as Swiss Federal Institutes of Technology ETH Zurich and EPFL, and the Paul Scherrer Institute (PSI). Companies collaborating with PARK INNOVAARE, one of Switzerland Innovation’s five sites, benefit from technology transfer platforms, state-of-the-art infrastructure and a unique atmosphere, which together foster the creation of the next best-selling products and services.

Basic Research

Video interview with Prof. Dr. Gebhard Schertler

In his interview with Switzerland Innovation Park Innovaare, Professor Dr. Gebhardt Schertler, Head of the Division of Biology and Chemistry at the Paul Scherrer Institute (PSI) and one of the brightest minds in structural biology, shares his views on the challenges and opportunities of modern drug discovery and the pivotal role of basic research.

Read the transcript of the interview here.